Ingvar Hjermann
Overview
Explore the profile of Ingvar Hjermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haheim L, Tonstad S, Hjermann I, Leren P, Holme I
Scand J Public Health
. 2007 Mar;
35(1):4-10.
PMID: 17366081
Aims: To test the association between body mass index (BMI) and other coronary risk factors and the risk of a fatal coronary heart disease (CHD) event in different time periods...
2.
Haheim L, Holme I, Hjermann I, Tonstad S
Scand J Public Health
. 2006 Nov;
34(6):589-97.
PMID: 17132592
Aims: To study the risk-factor profile for the incidence of non-fatal and fatal stroke among middle-aged men according to the stroke subtypes subarachnoid or intracerebral haemorrhage, cerebral infarction, and unspecified...
3.
Hjerkinn E, Abdelnoor M, Breivik L, Bergengen L, Ellingsen I, Seljeflot I, et al.
Eur J Cardiovasc Prev Rehabil
. 2006 Aug;
13(3):325-33.
PMID: 16926660
Background: This randomized study targeted a comparison of the effect of 3-year diet counselling or omega-3 polyunsaturated fatty acid (PUFA) supplementation (2.4 g/day) on the progression of atherosclerosis in carotid...
4.
Hjerkinn E, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L, et al.
Am J Clin Nutr
. 2005 Mar;
81(3):583-9.
PMID: 15755826
Background: Dietary factors and very-long-chain n-3 polyunsaturated fatty acids (n-3 PUFAs) may influence the atherothrombotic process. Elevated concentrations of circulating cell adhesion molecules, thrombomodulin (TM), von Willebrand factor (vWF), and...
5.
Anderssen S, Hjelstuen A, Hjermann I, Bjerkan K, Holme I
Atherosclerosis
. 2005 Feb;
178(2):387-97.
PMID: 15694949
Objectives: The Hypertension High Risk Management trial (HYRIM) investigated the effect of fluvastatin treatment and lifestyle intervention on development of carotid intima-media thickness (IMT) in drug-treated hypertensive patients. Methods And...
6.
Holme I, Tonstad S, Hjermann I
Tidsskr Nor Laegeforen
. 2004 Dec;
124(23):3039-42.
PMID: 15586182
Background: Between 1981 and 1991, the City of Oslo offered all its 40-year-old citizens screening for risk factors for cardiovascular disease. We describe changes in risk factors over this period....
7.
Haheim L, Holme I, Hjermann I, Leren P, Tonstad S
Scand Cardiovasc J
. 2004 Nov;
38(4):216-21.
PMID: 15553932
Objectives: To explore changes in the incidence of fatal and nonfatal myocardial infarction (MI) and stroke in the same male population over two decades. Design: Men aged 40-49 born in...
8.
Nafstad P, Haheim L, Wisloff T, Gram F, Oftedal B, Holme I, et al.
Environ Health Perspect
. 2004 Apr;
112(5):610-5.
PMID: 15064169
We investigated the association between total and cause-specific mortality and individual measures of long-term air pollution exposure in a cohort of Norwegian men followed from 1972-1973 through 1998. Data from...
9.
Klemsdal T, Tonstad S, Hjermann I
Tidsskr Nor Laegeforen
. 2004 Mar;
124(6):799-801.
PMID: 15039814
In spite of a substantial decline in the morbidity and the mortality from coronary heart disease in Norway since 1970-1975, cardiovascular disease remains the leading cause of death. The prevention...
10.
Ellingsen I, Hjermann I, Abdelnoor M, Hjerkinn E, Tonstad S
Am J Clin Nutr
. 2003 Nov;
78(5):935-40.
PMID: 14594779
Background: In the Oslo Diet and Antismoking Trial, 1232 high-risk men aged 40-49 y were randomly assigned to either a lifestyle intervention group or a control group for 5 y....